Cargando…

Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis

Detalles Bibliográficos
Autores principales:	Lucijanic, Marko, Cikara, Tomislav, Bistrovic, Petra, Papic, Ivan, Ortner Hadziabdic, Maja, Busic, Nikolina, Lackovic, Marina, Cesar, Natalia, Koscak, Valentina, Mitrovic, Josko, Barsic, Bruno, Lucijanic, Tomo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060712/ https://www.ncbi.nlm.nih.gov/pubmed/35513188 http://dx.doi.org/10.1016/j.jinf.2022.04.045

Ejemplares similares

Real-life experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital registry
por: Lucijanić, Marko, et al.
Publicado: (2022)

Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis
por: Bistrovic, Petra, et al.
Publicado: (2022)

Remdesivir-associated bradycardia might be a sign of good prognosis in COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2022)

Risks associated with prior oral anticoagulation use in hospitalized COVID-19 patients – A retrospective cohort study on 5392 patients from a tertiary centre
por: Bistrovic, Petra, et al.
Publicado: (2023)

Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events
por: Lucijanic, Marko, et al.
Publicado: (2023)

Predictors of prolonged hospitalization of COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2023)

P1563: REMDESIVIR USE IN SEVERE AND CRITICAL COVID-19 PATIENTS MIGHT BE ASSOCIATED WITH LOWER INCIDENCE OF ARTERIAL THROMBOTIC EVENTS
por: Lucijanic, Marko, et al.
Publicado: (2023)

Clinical and prognostic significance of C-reactive protein to albumin ratio in hospitalized coronavirus disease 2019 (COVID-19) patients: Data on 2309 patients from a tertiary center and validation in an independent cohort
por: Lucijanić, Marko, et al.
Publicado: (2022)

Pharmacists’ interventions improve health-related quality of life of rural older person on warfarin: a randomized controlled trial
por: Falamić, Slaven, et al.
Publicado: (2021)

Incidence and risk factors for venous and arterial thromboses in hospitalized patients with coronavirus disease 2019: data on 4014 patients from a tertiary center registry
por: Jurin, Ivana, et al.
Publicado: (2022)

Higher ferritin levels in COVID-19 patients are associated with hyperinflammation, worse prognosis, and more bacterial infections without pronounced features of hemophagocytosis
por: Lucijanic, Marko, et al.
Publicado: (2022)

Survival analysis, more than meets the eye
por: Lucijanic, Marko, et al.
Publicado: (2017)

Relative tachycardia at admission as a predictor of mortality in severe and critical COVID-19, a tertiary centre study
por: Bistrovic, P, et al.
Publicado: (2023)

The associations of age, sex, and comorbidities with survival of hospitalized patients with coronavirus disease 2019: data from 4014 patients from a tertiary-center registry
por: Piskač Živković, Nevenka, et al.
Publicado: (2022)

Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2022)

ECG characteristics associated with adverse outcomes in COVID-19, a tertiary centre experience
por: Bistrovic, P, et al.
Publicado: (2023)

Red cell distribution width is a potent prognostic parameter for in-hospital and post-discharge mortality in hospitalized coronavirus disease 2019 patients: a registry-based cohort study on 3941 patients
por: Lucijanić, Marko, et al.
Publicado: (2022)

The performance of the WHO COVID-19 severity classification, COVID-GRAM, VACO Index, 4C Mortality, and CURB-65 prognostic scores in hospitalized COVID-19 patients: data on 4014 patients from a tertiary center registry
por: Lucijanić, Marko, et al.
Publicado: (2023)

Survival analysis in clinical practice: analyze your own data using an Excel workbook
por: Lucijanić, Marko
Publicado: (2016)

An update to the custom-made MS Excel workbook performing the log-rank test with extended functionality and a new original COVID-19 training data set
por: Lucijanić, Marko
Publicado: (2021)

Survival after hospital discharge in patients hospitalized for acute coronavirus disease 2019: data on 2586 patients from a tertiary center registry
por: Lucijanić, Marko, et al.
Publicado: (2022)

Vaccine uptake in caregivers family members and patients with dementia and relationship with severity of dementia and caregiver burden: a cross-sectional study
por: Lucijanic, Jelena, et al.
Publicado: (2023)

PB2220: ATRIAL FIBRILLATION IS FREQUENT IN PATIENTS WITH MYELOFIBROSIS AND MIGHT BE SUB-OPTIMALLY TREATED
por: Lucijanic, Marko, et al.
Publicado: (2023)

Analysis of censored data
por: Lucijanic, Marko, et al.
Publicado: (2012)

Ruxolitinib withdrawal due to the COVID-19
por: Lucijanic, Marko, et al.
Publicado: (2021)

Duffy‐null erythrocyte phenotype and the risk of thrombotic events in essential thrombocythemia
por: Krecak, Ivan, et al.
Publicado: (2023)

A validation of the Croatian version of Zarit Burden Interview and clinical predictors of caregiver burden in informal caregivers of patients with dementia: a cross-sectional study
por: Lucijanić, Jelena, et al.
Publicado: (2020)

Incidence, Risk Factors and Mortality Associated with Major Bleeding Events in Hospitalized COVID-19 Patients
por: Lucijanic, Marko, et al.
Publicado: (2023)

P1621: INCIDENCE, RISK FACTORS AND MORTALITY ASSOCIATED WITH MAJOR BLEEDING EVENTS IN HOSPITALIZED COVID-19 PATIENTS, TERTIARY CENTER EXPERIENCE
por: Lucijanic, Marko, et al.
Publicado: (2023)

DIFFERENTIATED THYROID CANCER IN PEDIATRIC POPULATION (≤18 YEARS): POSTOPERATIVE TREATMENT WITH RADIOACTIVE IODINE (I-131)
por: Prpić, Marin, et al.
Publicado: (2019)

Relationship of Anxiety, Depression, Stress, and Post-Traumatic Stress Disorder Symptoms with Disease Severity in Acutely Ill Hospitalized COVID-19 Patients
por: Lucijanic, Dijana, et al.
Publicado: (2023)

Rituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected patients
por: Pejša, Vlatko, et al.
Publicado: (2017)

Epidemiological and clinical features of primary biliary cholangitis in two Croatian regions: a retrospective study
por: Madir, Anita, et al.
Publicado: (2019)

Development and Validation of Comprehensive Healthcare Providers’ Opinions, Preferences, and Attitudes towards Deprescribing (CHOPPED Questionnaire)
por: Bužančić, Iva, et al.
Publicado: (2022)

Differences in Factors Influencing Deprescribing between Primary Care Providers: Cross-Sectional Study
por: Bužančić, Iva, et al.
Publicado: (2023)

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms
por: Krečak, Ivan, et al.
Publicado: (2023)

USE OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH ADVANCED ACTIVE RHEUMATOID ARTHRITIS
por: Bobek, Dubravka, et al.
Publicado: (2022)

PB2219: POLYPHARMACY AND DRUG-TO-DRUG INTERACTIONS MAY HAVE A NEGATIVE EFFECT ON SURVIVAL IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS
por: Krecak, Ivan, et al.
Publicado: (2023)

Asymptomatic deep vein thromboses in prolonged hospitalized COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2021)

Organizing Pneumonia as a side-effect of Na-valproate- a case report
por: Rakos, I., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i7g3c2bc88svtckqstu98105ct